MIMETAS Expands Adult Stem Cell Organoid License to All Organs

 LEIDEN, The Netherlands, May 03, 2022 / B3C newswire / -- MIMETAS, a global leader in Organ-on-a-Chip models and technology, announces today that it has expanded its license to the HUB Organoid Technology to include all organs. The license covers organoid technology developed by Professor Hans Clevers, a pione...

Related Keywords

United States ,Netherlands ,Hans Clevers ,Jos Joore ,Bahar Ramezanpour ,Organoid Technology ,Drug Development ,Professor Hans Clevers ,Professor Hans ,Chief Business Officer ,Biological Assay ,High Throughput Screening Assays ,Lab Ona Chip Devices ,Drug Discovery ,Adult Stem Cells ,Inflammatory Bowel Diseases ,Connective Tissue ,